• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

使用新型跨腔异位装置对重度三尖瓣反流进行首次人体治疗。

First-in-Human Treatment of Severe Tricuspid Regurgitation Using a Novel Cross-Caval Heterotopic Device.

作者信息

Sisinni Antonio, Estévez-Loureiro Rodrigo, Caneiro-Queija Berenice, Barreiro-Pérez Manuel, Baz Jose A, Pazos Pablo, Gonzalez-Ferreiro Rocio, Iñiguez-Romo Andrés

机构信息

Department of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain.

Cardiovascular Research Group, Department of Cardiology, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IIS Galicia Sur), Servizo Galego de Saude, University of Vigo, Vigo, Spain.

出版信息

JACC Case Rep. 2023 Nov 2;28:102103. doi: 10.1016/j.jaccas.2023.102103. eCollection 2023 Dec 20.

DOI:10.1016/j.jaccas.2023.102103
PMID:38204550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10774827/
Abstract

A 79-year-old woman, previously surgically treated for mitral and aortic valve replacement, experienced recurrent torrential tricuspid regurgitation after 2 transcatheter edge-to-edge repair procedures. Heart team assessment deemed the patient high risk for redo surgery and excluded transcatheter edge-to-edge repair and orthotopic replacement. The patient was then scheduled for a novel cross-caval device implantation.

摘要

一名79岁女性，此前接受过二尖瓣和主动脉瓣置换手术，在两次经导管缘对缘修复手术后出现复发性严重三尖瓣反流。心脏团队评估认为该患者再次手术风险高，排除了经导管缘对缘修复和原位置换。随后该患者被安排进行一种新型跨腔静脉装置植入。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6fd/10774827/b92dd6686865/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6fd/10774827/ff48b0ce6f85/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6fd/10774827/b92dd6686865/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6fd/10774827/ff48b0ce6f85/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6fd/10774827/b92dd6686865/gr1.jpg

相似文献

1
First-in-Human Treatment of Severe Tricuspid Regurgitation Using a Novel Cross-Caval Heterotopic Device.使用新型跨腔异位装置对重度三尖瓣反流进行首次人体治疗。
JACC Case Rep. 2023 Nov 2;28:102103. doi: 10.1016/j.jaccas.2023.102103. eCollection 2023 Dec 20.
2
Transcatheter Caval Valve Implantation for Tricuspid Regurgitation After Single Leaflet Device Attachment.单叶瓣装置附着后经导管植入腔静脉瓣膜治疗三尖瓣反流
JACC Case Rep. 2022 Apr 20;4(8):481-485. doi: 10.1016/j.jaccas.2022.02.014.
3
Heterotopic Transcatheter Tricuspid Valve Replacement in Severe Tricuspid Regurgitation and Refractory Right Heart Failure.严重三尖瓣反流和难治性右心衰竭的异位经导管三尖瓣置换术
JACC Case Rep. 2022 Aug 17;4(16):1005-1011. doi: 10.1016/j.jaccas.2022.03.038.
4
Transcatheter Treatment of Valvular Heart Disease: A Review.经导管瓣膜病治疗：综述。
JAMA. 2021 Jun 22;325(24):2480-2494. doi: 10.1001/jama.2021.2133.
5
Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial.爱德华兹- Sapien XT经导管瓣膜在下腔静脉异位植入治疗严重三尖瓣反流（HOVER）试验的研究设计与原理
Catheter Cardiovasc Interv. 2016 Aug;88(2):287-93. doi: 10.1002/ccd.26530. Epub 2016 Apr 28.
6
Heterotopic caval valve implantation in severe tricuspid regurgitation.三尖瓣重度反流时的异位腔静脉瓣植入术。
Ann Card Anaesth. 2021 Jul-Sep;24(3):365-368. doi: 10.4103/aca.ACA_72_20.
7
Advances in transcatheter mitral and tricuspid therapies.经导管二尖瓣和三尖瓣治疗的进展。
BMC Cardiovasc Disord. 2020 Jan 7;20(1):1. doi: 10.1186/s12872-019-01312-3.
8
Percutaneous tricuspid valve replacement: orthotopic and heterotopic valves.经皮三尖瓣置换术：原位和异位瓣膜
Minerva Cardioangiol. 2018 Dec;66(6):729-734. doi: 10.23736/S0026-4725.18.04659-5. Epub 2018 Mar 28.
9
Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation.经导管异位三尖瓣植入术：一种治疗三尖瓣反流的新方法的首例人体应用。
Eur Heart J. 2011 May;32(10):1207-13. doi: 10.1093/eurheartj/ehr028. Epub 2011 Feb 7.
10
Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation.腔静脉瓣植入术（CAVI）：一种治疗重度三尖瓣反流的新兴疗法。
J Clin Med. 2021 Oct 7;10(19):4601. doi: 10.3390/jcm10194601.

引用本文的文献

1
Transcatheter Caval Implantation for Severe Tricuspid Regurgitation.经导管腔静脉植入术治疗重度三尖瓣反流
Curr Cardiol Rep. 2025 Jan 7;27(1):7. doi: 10.1007/s11886-024-02190-8.